Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Clinical trial NCT03864042 · COMPLETED
Trial details
- NCT number
- NCT03864042
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-02
- Primary completion
- 2022-07-11
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.